|
Fluticasone, Propionate - Concentration/Dosage 250 Mcg, Pharmaceutical Form Powder For Inhalation, Inhalation Route Of Administration, Fluvoxamine - Concentration Dosage 100Mg, Pharmaceutical Form In Tablets, Presentation Form In Tablets, Oral Administration Route.., Gabapentin - Concentration/Dosage 300 Mg, Form Farmaceutica Capsule, Oral Route Of Administration, Gabapentin - Concentration/Dosage 400 Mg, Gliclazide - Concentration/Dosage 30 Mg, Prolonged Release Tablet Pharmaceutical Form, Oral Administration Route, 04/07/2026 - 12:42:32, 04/07/2026 - 12:42:36, 07/04/2026 - 12:42:38, Gliclazide - Concentration/Dosage 60Mg, Pharmaceutical Form Extended Release Tablet, Glucosamine, Sulfate + Chondroitin, Sulfate - Concentration/Dosage 1500 Mg+ 1200 Mg Respectively, Pharmaceutical Form Sachet, Presentation Form In Sachet, Sulfate - Concentration/Dosage 500 Mg +400 Mg Respectively, Goserelin, Acetate - 3.6 Mg, In Injectable Solution, Syringe Filled With Safety Device,., Acetate - 10.8 Mg, Sodium Hyaluronate - Sodium Hyaluronate 0.15% (1, 5Mg/Ml), In Pharmaceutical Form Of Sterile Ophthalmic Solution, Indacaterol, Maleate - Concentration/Dosage 150 Mcg, Pharmaceutical Form Capsule With Powder For Inhalation As Specified On The Product Packaging., Insulin Glulisine - Concentration/Dosage 100 Iu/Ml, Pharmaceutical Form Injectable Solution, Pen Presentation Form Prefilled, Subcutaneous Administration Route, Imipramine, Hydrochloride - Concentration/Dosage 25 Mg, Pharmaceutical Form Dragee, Ivabradine - - Hydrochloride, Concentration/Dosage 7.5Mg, Pharmaceutical Form Tablet, Tablet Presentation Form, Lacosamide - Lacosamide 200Mg, Pharmaceutical Form Coated Tablet, As Per It Appears In The Product Registration. The Packaging Must Externally Contain The Identification Data, Batch, Manufacturing And Expiration Dates. The Product Must Have A Minimum Validity Of 12 Months From Delivery To The Requesting Unit., Lamotrigine - Concentration/Dosage 100 Mg, Oral Administration Route, Latanoprost - Concentration/Dosage 50 Mcg/Ml, Pharmaceutical Form Ophthalmic Solution, Bottle Presentation Form, Ophthalmic Route Of Administration, Leflunomide - Concentration/Dosage 20 Mg, Coated Tablet Pharmaceutical Form, Levetiracetam - Pharmaceutical Form, Tablet, Via Oral Administration, Concentration And Dosage 500Mg, Lidocaine, Hydrochloride - Lidocaine Hydrochloride 2%, Jelly Pharmaceutical Form (Tube), Packaged As Appeared In The Product Registration. The Packaging Must Bear External Identification Data, Batch Number, Manufacturing Date And Expiration Date. On The Delivery Date, The Product Must Have At Least 75% Of Its Total Shelf Life. According To Ordinance 2814 Gm/1998, The Product Must Present On Its Primary And/Or Secondary Packaging The Expression Forbidden To Be Sold In Commerce. Filled., Lisdexamfetamine Dimesylate - Dosage Concentration 30Mg, Pharmaceutical Form In Capsule, Capsule Presentation Form, Oral Administration Route, Lisdexamfetamine Dimesylate - Dosage Concentration 50Mg
|
